BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
A message from NAC International
NAC International Showcases Capabilities as Supplier for SMR and AR Developers
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Orano Med inaugurates Pb-212 production facility in Indiana
Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated its first ATLab (Alpha Therapy Laboratory) earlier this month. Located in Brownsburg, near...
ANS Annual Conference special plenary: Our friends the isotopes
“What can the atom do for you, other than produce electricity from nuclear reactors?” That was the question asked and answered during an ANS Annual Conference special plenary session on...
Oklo’s Diané presents at Community of Practice
The American Nuclear Society’s Risk-informed, Performance-based Principles and Policy Committee (RP3C) held another Community of Practice (CoP) on April 26. For this event, the committee...
Americium-241 heat source planned for Mars rover in a space exploration first
Europe’s first Mars rover—named Rosalind Franklin—was months away from a planned September launch when the European Space Agency (ESA) convened a meeting a few weeks after Russia’s...
Oklo to collaborate with Atomic Alchemy on isotope production
Fast reactor developer Oklo, which recently went public on the New York Stock Exchange, announced on May 13 that it has signed a memorandum of understanding with Atomic Alchemy to cooperate on...
Strontium: Supply-and-demand success for the DOE’s Isotope Program
The Department of Energy’s Isotope Program (DOE IP) announced last week that it would end its “active standby” capability for strontium-82 production about two decades after beginning...
Framatome, KHNP to investigate producing Lu-177 in South Korea
Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...
Radioisotopes target cancer, improve imaging, and have myriad other medical uses
On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...
The road to wellness: The task of getting lifesaving medical isotopes to patients
According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...
Germany’s ITM receives material license to produce Lu-177
Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...